McClellan R O, Miller F J, Hesterberg T W, Warheit D B, Bunn W B, Kane A B, Lippmann M, Mast R W, McConnell E E, Reinhardt C F
Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709.
Regul Toxicol Pharmacol. 1992 Dec;16(3):321-64. doi: 10.1016/0273-2300(92)90011-w.
The Workshop on Approaches to Evaluating the Toxicity and Carcinogenicity of Man-Made Fibers (MMF) was held in Durham, North Carolina, on November 11-13, 1991. The goal of the workshop was to reach a consensus, or to determine the extent to which a consensus existed, in two areas. Participants were asked to identify scientifically sound approaches for evaluating the toxicity and carcinogenicity of man-made fibers based on today's science and to determine research appropriate for study during the next 5 years that can provide an improved scientific basis for future revisions of approaches used to evaluate man-made fiber toxicity and carcinogenicity. During the first day, a series of "state of knowledge" presentations were made to provide all participants with a common data base from which to interact and discuss scientific issues. The workshop participants were assigned to one of four discussion groups, which met separately in three half-day sessions following the first day of presentations. All groups discussed the same topics: exposure assessment, hazard identification, and dose-response information needed to integrate to characterize risk in the first session; approaches to obtaining the needed information in the second session; and recommended approaches and guidelines for evaluating the toxicity and carcinogenicity of MMF and research needs in the third session. The workshop participants reconvened as a whole after each discussion session, and one member from each group reported the group's conclusions. A closure period was also included at the end of the workshop for review and discussion of items that had been considered during the workshop. The primary conclusions reached were the following: -All fiber types capable of depositing in the thorax are not alike in their pathogenic potential. -Only fiber samples with dimensions similar to those to which humans can inhale should be tested. -A complete characterization (i.e., dimensions, fiber number, mass, and aerodynamic diameter) of the fiber aerosol and retained dose is essential. -Appropriate aerosol generation methods must be used for inhalation studies in order to preserve fiber lengths. -A tiered approach to toxicity evaluation is recommended that includes: 1. In vitro screening for durability, surface properties, cytotoxicity, and similar properties, etc; 2. Short-term inhalation or other in vivo studies; 3. That chronic inhalation studies are the "gold standard" (i.e., provide most appropriate data for risk characterization). -The rat is the most appropriate species for inhalation studies. -In chronic inhalation studies, animals should be retained to at least 20% survival after 2-year exposure. -Serial lung burden analyses are an essential component of inhalation studies and are essential for understanding exposure-dose-response relationships. -Studies oriented to understanding mechanisms of toxicity and carcinogenicity are important adjuncts to traditional toxicity studies. -Histopathological analyses of tissues of the respiratory tract represent primary endpoints for evaluating effects of inhaled fibers. Major effects include pulmonary fibrosis, lung tumors, and mesotheliomas. Experimental tissues should be archived for future studies; wherever possible, handling and preservation of tissues should be done in a way that maximizes their future use in mechanistic studies. -Potential human exposures throughout the entire life-cycle of the fiber must be considered and fibrous material for toxicologic studies prepared accordingly. -Intracavity studies are inappropriate for risk characterization but can play a useful screening role in assessing fiber toxicity.(ABSTRACT TRUNCATED AT 400 WORDS)
“人造纤维(MMF)毒性和致癌性评估方法研讨会”于1991年11月11日至13日在北卡罗来纳州达勒姆市举行。该研讨会的目标是在两个领域达成共识,或确定已达成共识的程度。要求参会者基于当今科学,确定评估人造纤维毒性和致癌性的科学合理方法,并确定未来5年适合开展的研究,以便为未来修订人造纤维毒性和致癌性评估方法提供更完善的科学依据。在第一天,进行了一系列“知识现状”报告,为所有参会者提供一个共同的数据库,以便相互交流和讨论科学问题。研讨会参会者被分成四个讨论小组之一,在第一天报告之后,分三个半天会议分别进行讨论。所有小组讨论相同的主题:在第一场会议中讨论整合以表征风险所需的暴露评估、危害识别和剂量反应信息;在第二场会议中讨论获取所需信息的方法;在第三场会议中讨论评估MMF毒性和致癌性的推荐方法和指南以及研究需求。每次讨论会议后,研讨会参会者全体重新集合,每组一名成员汇报小组结论。在研讨会结束时还安排了一个总结期,用于回顾和讨论研讨会期间审议的事项。得出的主要结论如下:
所有能够沉积在胸部的纤维类型,其致病潜力并不相同。
仅应测试尺寸与人可吸入尺寸相似的纤维样本。
对纤维气溶胶和留存剂量进行完整表征(即尺寸、纤维数量、质量和空气动力学直径)至关重要。
吸入研究必须使用合适的气溶胶生成方法以保持纤维长度。
建议采用分层毒性评估方法,包括:1. 进行体外耐久性、表面特性、细胞毒性等类似特性的筛选;2. 进行短期吸入或其他体内研究;3. 慢性吸入研究是“金标准”(即提供最适合风险表征的数据)。
大鼠是吸入研究最合适的物种。
在慢性吸入研究中,动物在2年暴露后应留存至至少20%存活。
连续肺负荷分析是吸入研究的重要组成部分,对于理解暴露-剂量-反应关系至关重要。
旨在理解毒性和致癌机制的研究是传统毒性研究的重要辅助。
呼吸道组织的组织病理学分析是评估吸入纤维效应的主要终点。主要影响包括肺纤维化、肺癌和间皮瘤。实验组织应存档以备未来研究;只要可能,组织的处理和保存方式应使其在未来机制研究中的用途最大化。
必须考虑纤维整个生命周期内潜在的人体暴露,并据此制备用于毒理学研究的纤维材料。
腔内研究不适用于风险表征,但在评估纤维毒性方面可发挥有用的筛选作用。(摘要截选至400词)